The Cardiovascular Research Group is a dynamic multi-disciplinary team of epidemiologists, biostatisticians, and health practitioners examining trends and models of care in cardiovascular disease prevention, treatment and management.
Cardiovascular disease is the leading cause of morbidity and mortality in Australia and worldwide.
Modifiable risk factors such as hypertension, dyslipidaemia, smoking, diabetes, and obesity have been shown to play a significant role in the burden of cardiovascular disease. Evidence-based prevention and treatment approaches have evolved significantly over the past two decades, leading to reductions in rates of many cardiovascular conditions. However, the reported rise in the prevalence of diabetes and obesity has the potential to reverse these trends.
Treatment for cardiovascular disease, including medications and invasive procedural techniques, continue to evolve rapidly and have the potential to impact on cardiovascular outcomes.
Epidemiological research plays an important role in monitoring and identifying determinants, trends, and outcomes for cardiovascular disease.
Our group has a long and distinguished history which includes the WHO MONICA Project and the Busselton Health Study. The group has received tens of millions of dollars in nationally competitive research funds, including $5 million over the last five years. We are involved in a wide range of current studies with local, national and international partners.
A representative sample of our research interests include:
For further information, please contact the Head of the Cardiovascular Research Group, Research Associate Professor Tom Briffa